Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections - a scoping review

Simple item page

Simple item page

Full item details

creativework.keywords - en
Burden of illness
Campylobacter spp.
fluoroquinolone resistance
human infections
scoping review
Anti-Bacterial Agents
Cost of Illness
Quinolones
dc.contributor.author
Isada, M. J.
Reist, M.
MacKinnon, M. C.
Uhland, F. C.
Young, K. M.
Gibbens, K.
Parmley, E. J.
Carson, C. A.
dc.date.accessioned
2024-04-02T14:37:22Z
dc.date.available
2024-04-02T14:37:22Z
dc.date.issued
2022-11
dc.description.abstract - en
Campylobacter spp. are one of the most common causes of bacterial gastroenteritis in Canada and worldwide. Fluoroquinolones are often used to treat complicated human campylobacteriosis and strains of Campylobacter spp. resistant to these drugs are emerging along the food chain. A scoping review was conducted to summarise how human (fluoro)quinolone-resistant (FQR; quinolones including fluoroquinolones) Campylobacter spp. infections are charac terised in the literature by describing how burden of illness (BOI) associated with FQR is measured and reported, describing the variability in reporting of study characteristics, and providing a narrative review of literature that compare BOI measures of FQR Campylobacter spp. infections to those with susceptible infections. The review identified 26 studies that yielded many case reports, a lack of recent literature and a lack of Canadian data. Studies reported 26 different BOI measures and the most common were hospitalisation, diarrhoea, fever and duration of illness. There were mixed results as BOI measures reported in literature were inconsistently defined and there were limited comparisons between resistant and susceptible infections. This presents a challenge when attempting to assess the magnitude of the BOI due to FQR Campylobacter spp., highlighting the need for more research in this area.
dc.identifier.citation
Isada MJ, Reist M, MacKinnon MC, Uhland FC, Young KM, Gibbens K, Parmley EJ, Carson CA. Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections - a scoping review. Epidemiol Infect. 2022 Nov 11;150:e205. doi: 10.1017/S095026882200139X.
dc.identifier.doi
https://doi.org/10.1017/ S095026882200139X
dc.identifier.issn
0950-2688
dc.identifier.pubmedID
36519309
dc.identifier.uri
https://open-science.canada.ca/handle/123456789/2210
dc.language.iso
en
dc.publisher
Cambridge University Press
dc.rights - en
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights - fr
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights.uri - en
https://creativecommons.org/licenses/by/4.0/
dc.rights.uri - fr
https://creativecommons.org/licenses/by/4.0/deed.fr
dc.subject - en
Health
dc.subject - fr
Santé
dc.subject.en - en
Health
dc.subject.fr - fr
Santé
dc.title - en
Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections - a scoping review
dc.type - en
Article
dc.type - fr
Article
local.acceptedmanuscript.articlenum
205
local.article.journaltitle
Epidemiology and Infection
local.article.journalvolume
150
local.peerreview - en
Yes
local.peerreview - fr
Oui
Download(s)

Original bundle

Now showing 1 - 1 of 1

Thumbnail image

Name: isada-burden-illness-quinoline-resistant-campylobacter.pdf

Size: 436.46 KB

Format: PDF

Download file

Page details

Date modified: